/
Not financial advice. Analytical data for research only.
Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.
Solitron Devices, Inc., a Delaware corporation (the "Company" or "Solitron"), designs, develops, manufactures and markets solid state semiconductor components and related devices primarily for the military and aerospace markets. The Company manufactures a large variety of bipolar and metal oxide semiconductor ("MOS") power transistors, power and control hybrids, junction and power MOS field eff…
$31.53
$0.97 (-2.98%)
EOD Sep 1, 2026
Operating margin is thin at 9.53%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue up 20.8% YoY with margins expanding 2.4pp.
At 32x earnings, the current multiple leaves limited room for execution misses or growth deceleration.
31.6x earnings, 24.9x FCF. Not cheap, the quality is already reflected in the price. Upside from here requires either margin expansion or growth re-acceleration, not just continuation.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$20M
▲ +20.8% YoY
Net Income (TTM)
$2M
▼ -1.0% YoY
Op. Margin
17.92%
▲ +2.4pp YoY
ROIC
0.29%
▲ +2.1pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$3M
▲ +82.7% YoY
Op. Cash Flow (TTM)
$3M
▼ -43.7% YoY
Net Debt
$3.72B
Cash & Equiv.
$6M
5Y CAGR: +10.0%
5Y CAGR: -8.5%
Continue Research
SourceComputed from the 10-Q filed 13 Jul 2026, covering the period ending 31 May 2026, as reported to the SEC. Data last refreshed 14 Jul 2026. How this is calculated.
Price from market data, last close as of 1 Sept 2026. Fiscal year ends Feb. Sector medians are approximate S&P 500 benchmarks and update periodically.
At a P/E of 31.6 and a price-to-free-cash-flow of 24.9, Solitron Devices (SODI) trades above a two-stage DCF intrinsic value of about $-1,662.70 per share, so at $31.53 the stock looks overvalued (5,373.4% above estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Solitron Devices scores 64/100 on Intrinsiqq's quality scorecard (a solid business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Intrinsiqq's two-stage DCF estimates an intrinsic value of about $-1,662.70 per share for SODI, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around $-1,247.03. At today's $31.53, that puts the stock about 5,373.4% above estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
Solitron Devices scores 64 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which makes it a solid business on these measures. Recent fundamentals include a 17.9% operating margin and a 0.3% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. SODI currently trades above its estimated intrinsic value and scores 64/100 on quality (solid). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.